BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

138 hedge funds and large institutions have $2.53B invested in Blueprint Medicines in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
+14
Holders Change %
+11.29%
% of All Funds
3.45%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.2%
New
29
Increased
51
Reduced
40
Closed
14
Calls
$3.51M
Puts
$2.63M
Net Calls
+$877K
Net Calls Change
+$2.38M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$409M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$135M
3
PHS
3
PFM Health Sciences
California
$113M
4
TCM
4
TimesSquare Capital Management
New York
$60.5M
5
PAMU
5
Pictet Asset Management (UK)
United Kingdom
$42.1M

Top Sellers

1
BI
1
BVF Inc
California
$70.2M
2
DCM
2
Driehaus Capital Management
Illinois
$12.9M
3
CAM
3
Cormorant Asset Management
Massachusetts
$5.23M
4
RG
4
Redmile Group
California
$0
5
NI
5
Numeric Investors
Massachusetts
$1.33M
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
151
Prelude Capital Management
New York
– -$12K -235 Closed
Creative Planning
152
Creative Planning
Kansas
– -$5K -100 Closed
3 4 5 6
7